Shanghai Microport Endovascular Medtech(Group)Co.688016.SHValuation Analysis

As of Oct 19, 2026, Shanghai Microport Endovascular Medtech(Group)Co. (688016.SH) trades at a P/E of 17.90x, P/B of 2.40x, P/S of 6.43x, and a dividend yield of 2.72%.
Longitudinal percentile comparison: P/E sits at the 2nd percentile over the trailing 10Y window (vs. 5th percentile over 3Y); P/B sits at the 0th percentile over the trailing 10Y window (vs. 1st percentile over 3Y); P/S sits at the 2nd percentile over the trailing 10Y window (vs. 4th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 18th percentile within its industry and the 20th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 3.90%, ranking at the 100th percentile over the trailing 20Y window.
The P/E and P/B long-window percentiles differ by only 1.8 points, pointing to a consistent valuation read across both metrics. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Breaking down the total shareholder yield: 2.72% comes from cash dividends, with an implied ~1.18% from buybacks — a fairly balanced mix of both channels. Shanghai Microport Endovascular Medtech(Group)Co. operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.